Validation study of colorectal cancer treatment effect prediction by metabolomic markers
Not Applicable
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000037904
- Lead Sponsor
- Keio University school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
1.A case with double cancer 2.Patient who need additional drugs which affect the evaluation of anti-tumor effects of FOLFOIX +BV or CapeOX + BV. 3.Patients who are judged inappropriate by physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best clinical response (RECIST 1.1) Serum concentration of metabolomic markers
- Secondary Outcome Measures
Name Time Method Overall survival